While the authors have published other reports on the tau tracer (87, 88), no studies appear to have been published on the trial results, which seem to indicate that the AD did indeed have more amyloid and tau PET activity than either the CTE or healthy athlete control group, although the tau specific hypothesis may not have been borne out given the preliminary data available. Here, MAPT is linked to Alzheimer disease.